CVS Health Co. (NYSE:CVS) Stake Reduced by Callahan Advisors LLC
Callahan Advisors LLC cut its holdings in CVS Health Co. (NYSE:CVS – Free Report) by 14.3% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 29,248 shares of the pharmacy operator’s stock after selling 4,886 shares during the quarter. Callahan Advisors…
This article is available to Insider Pro subscribers only.Sign in or register to be an Insider Pro and access ALL LOCKED articles.
FutureProof Technologies Launches FutureProof Insurance Agency to Leverage AI-Driven Risk Selection for Carrier Partners
Kentucky Retirement Systems Insurance Trust Fund Sells 3,677 Shares of Analog Devices, Inc. (NASDAQ:ADI)
Advisor News
- Midlife planning for women: why it matters and how advisors should adapt
- Tax anxiety is real, although few have a plan to address it
- Trump targets ‘retirement gap’ with new executive order
- Younger investors are engaged and advisors must adapt
- Plugging the hidden budget leaks of retirement
More Advisor NewsAnnuity News
- AM Best Assigns Credit Ratings to Calix Re Limited
- Transamerica introduces new RILA with optional income features
- Transamerica introduces RILA with optional income features
- American Life expands into Wyoming and Mississippi markets
- Knighthead Life Enters U.S. Fixed Indexed Annuity Market
More Annuity NewsHealth/Employee Benefits News
- Four-part Medicare education series planned at Viroqua library
- Florida state employee health insurance premiums frozen for 2026-27
- Health insurer settles $5M ‘deceptive marketing’ lawsuit with Mass. AG
- Why are rates going up?
- REPUBLICANS DID THAT: Millions of Americans Drop ACA Coverage After GOP Allowed Tax Credits to Expire
More Health/Employee Benefits NewsLife Insurance News
- Transamerica agrees to $57M settlement in cost-of-insurance lawsuit
- The next step for AI in insurance — partnerships to scale
- Your clients are sitting on underused assets
- National Life Group Names Jason Doiron CEO of NLG Capital to Lead the Next Phase of Growth
- Life insurance sales surge 7% in 2025, but the work isn’t over
More Life Insurance News